
|Articles|December 1, 2004
Transaction is a surprise, but makes sense, analysts say
Although the news of Advanced Medical Optics Inc. (AMO) buying VISX caught many on Wall Street off guard, several analysts are saying the deal makes sense in retrospect.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Beyond the surface: Tackling complex dry eye cases
2
Seborrheic dermatitis linked to multiple epithelial barrier diseases
3
Q&A: Anat Loewenstein discusses the use of home OCT
4
Redefining glaucoma care: Where innovation meets clinical insight
5


















































.png)


